ALGN vs MGNX · P/E 35, rev $2.10B vs rev $39.6M
Align Technology Inc (ALGN) versus MacroGenics Inc (MGNX) — a side-by-side from cached financials, not a winner call.
Align Technology Inc (ALGN) is a medical instruments & supplies company listed on US.
MacroGenics Inc (MGNX) is a biotechnology company listed on NASDAQ.
Latest reported ALGN revenue for 2026-06-30 was $2.10B. Net income was $221.1M. ALGN currently screens at market cap $14.17B and trailing P/E 35.2.
Latest reported MGNX revenue for 2026-06-30 was $39.6M. Net income was -$17.3M. Revenue was up 90.4% from 2026-03-31 to 2026-06-30. MGNX currently screens at market cap $246.6M.
ALGN currently screens at market cap $14.17B and trailing P/E 35.2. MGNX currently screens at market cap $246.6M.
Not investment advice. Open the ALGN and MGNX stock pages for the full models.
Not investment advice.